These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 30935845)

  • 1. The Cancer of the Bladder Risk Assessment (COBRA) score for predicting cancer-specific survival after radical cystectomy for urothelial carcinoma of the bladder: External validation in a cohort of Korean patients.
    Kim HS; Kwak C; Kim HH; Ku JH
    Urol Oncol; 2019 Jul; 37(7):470-477. PubMed ID: 30935845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Cancer of the Bladder Risk Assessment (COBRA) score for estimating cancer-specific survival after radical cystectomy: external validation in a large bi-institutional cohort.
    Muilwijk T; Akand M; Soria F; Giordano A; Milenkovic U; Moris L; Gevaert T; Van Poppel H; Albersen M; Gontero P; Joniau S
    BJU Int; 2020 Dec; 126(6):704-714. PubMed ID: 32640103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making.
    Aziz A; Shariat SF; Roghmann F; Brookman-May S; Stief CG; Rink M; Chun FK; Fisch M; Novotny V; Froehner M; Wirth MP; Schnabel MJ; Fritsche HM; Burger M; Pycha A; Brisuda A; Babjuk M; Vallo S; Haferkamp A; Roigas J; Noldus J; Stredele R; Volkmer B; Bastian PJ; Xylinas E; May M
    BJU Int; 2016 Feb; 117(2):272-9. PubMed ID: 25381844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Cancer of the Bladder Risk Assessment (COBRA) score accurately predicts cancer-specific survival after radical cystectomy: external validation and lymphovascular invasion assessment value to improve its performance.
    Colomer Gallardo A; Candela L; Buisan Rueda O; Freixa Sala R; Elias Cañavera J; Moschini M; Macek P; Bennamoun M; Mombet A; Cathelineau X; Areal Calama JJ; Sánchez-Salas R
    Clin Genitourin Cancer; 2022 Jun; 20(3):199-209. PubMed ID: 35042666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Cancer of the Bladder Risk Assessment (COBRA) score: Estimating mortality after radical cystectomy.
    Welty CJ; Sanford TH; Wright JL; Carroll PR; Cooperberg MR; Meng MV; Porten SP
    Cancer; 2017 Dec; 123(23):4574-4582. PubMed ID: 28881475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the COBRA nomogram for the prediction of cancer specific survival in patients treated with radical cystectomy for bladder cancer: An international wide cohort study.
    De Nunzio C; Franco A; Simone G; Tuderti G; Anceschi U; Brassetti A; Daneshmand S; Miranda G; Desai MM; Gill I; Abol-Enein H; Molinaro E; Nacchia A; Lombardo R; Leonardo C; Tubaro A
    Eur J Surg Oncol; 2021 Oct; 47(10):2646-2650. PubMed ID: 33966945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder.
    Nuhn P; May M; Sun M; Fritsche HM; Brookman-May S; Buchner A; Bolenz C; Moritz R; Herrmann E; Burger M; Tilki D; Trojan L; Perrotte P; Haferkamp A; Hohenfellner M; Wieland WF; Müller SC; Karakiewicz PI; Bastian PJ
    Eur Urol; 2012 Jan; 61(1):58-64. PubMed ID: 21840642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a.
    May M; Bastian PJ; Brookman-May S; Fritsche HM; Tilki D; Otto W; Bolenz C; Gilfrich C; Trojan L; Herrmann E; Moritz R; Tiemann A; Müller SC; Ellinger J; Buchner A; Stief CG; Wieland WF; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Nuhn P; Burger M
    Urol Oncol; 2013 Oct; 31(7):1141-7. PubMed ID: 22056404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and external validation of nomograms predicting disease-free and cancer-specific survival after radical cystectomy.
    Simone G; Bianchi M; Giannarelli D; Daneshmand S; Papalia R; Ferriero M; Guaglianone S; Sentinelli S; Colombo R; Montorsi F; Collura D; Muto G; Novara G; Hurle R; Rink M; Fisch M; Abol-Enein H; Miranda G; Desai M; Gill I; Gallucci M
    World J Urol; 2015 Oct; 33(10):1419-28. PubMed ID: 25542395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a prognostic nomogram for predicting cancer-specific survival after radical cystectomy in patients with bladder cancer:A population-based study.
    Yang Z; Bai Y; Liu M; Hu X; Han P
    Cancer Med; 2020 Dec; 9(24):9303-9314. PubMed ID: 33063464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External validation of preoperative and postoperative nomograms for prediction of cancer-specific survival, overall survival and recurrence after robot-assisted radical cystectomy for urothelial carcinoma of the bladder.
    Al-Daghmin A; English S; Kauffman EC; Din R; Khan A; Syed JR; Sztorc J; Mehedint D; Sharif M; Shi Y; Wilding G; Guru KA
    BJU Int; 2014 Aug; 114(2):253-60. PubMed ID: 24119175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External validation of online predictive models for prediction of cancer-specific mortality and all-cause mortality in patients with urothelial carcinoma of the urinary bladder.
    Moon KC; Kim M; Kwak C; Kim HH; Ku JH
    Ann Surg Oncol; 2014 Sep; 21(9):3132-41. PubMed ID: 24590433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Karnofsky performance status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma.
    Evers PD; Logan JE; Sills V; Chin AI
    World J Urol; 2014 Apr; 32(2):385-91. PubMed ID: 23756991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nomograms provide improved accuracy for predicting survival after radical cystectomy.
    Shariat SF; Karakiewicz PI; Palapattu GS; Amiel GE; Lotan Y; Rogers CG; Vazina A; Bastian PJ; Gupta A; Sagalowsky AI; Schoenberg M; Lerner SP
    Clin Cancer Res; 2006 Nov; 12(22):6663-76. PubMed ID: 17121885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis.
    Vetterlein MW; Seisen T; May M; Nuhn P; Gierth M; Mayr R; Fritsche HM; Burger M; Novotny V; Froehner M; Wirth MP; Protzel C; Hakenberg OW; Roghmann F; Palisaar RJ; Noldus J; Pycha A; Bastian PJ; Trinh QD; Xylinas E; Shariat SF; Rink M; Chun FK; Dahlem R; Fisch M; Aziz A;
    Eur Urol Focus; 2018 Mar; 4(2):252-259. PubMed ID: 28753775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Routine Laboratory Parameters in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: A Long-Term Follow-Up.
    Tamalunas A; Buchner A; Kretschmer A; Jokisch F; Schulz G; Eismann L; Stief CG; Grimm T
    Urol Int; 2020; 104(7-8):551-558. PubMed ID: 32114587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
    Karakiewicz PI; Shariat SF; Palapattu GS; Gilad AE; Lotan Y; Rogers CG; Vazina A; Gupta A; Bastian PJ; Perrotte P; Sagalowsky AI; Schoenberg M; Lerner SP
    J Urol; 2006 Oct; 176(4 Pt 1):1354-61; discussion 1361-2. PubMed ID: 16952631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radical cystectomy for pT1 urothelial carcinoma of bladder not amenable to TURBT: Long-term results.
    Ma B; Li Y; Han S; Jiang X; Zhao Y; Guo J; Quan C; Niu Y
    Eur J Surg Oncol; 2019 Oct; 45(10):1993-1999. PubMed ID: 31327502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy.
    Xylinas E; Rink M; Robinson BD; Lotan Y; Babjuk M; Brisuda A; Green DA; Kluth LA; Pycha A; Fradet Y; Faison T; Lee RK; Karakiewicz PI; Zerbib M; Scherr DS; Shariat SF
    Eur J Cancer; 2013 May; 49(8):1889-97. PubMed ID: 23466126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk prediction models of locoregional failure after radical cystectomy for urothelial carcinoma: external validation in a cohort of korean patients.
    Ku JH; Kim M; Jeong CW; Kwak C; Kim HH
    Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1032-1037. PubMed ID: 25035206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.